SureNano Announces Closing of $1,250,000 Private Placement

Rhea-AI Summary

SureNano (OTCQB: SURNF) closed a non-brokered private placement on December 10, 2025 raising $1,250,000 by issuing 10,000,000 Units at $0.125 per Unit. Each Unit includes one common share and one warrant exercisable at $0.35 for 24 months.

The warrants and 600,000 finder’s warrants carry an acceleration provision if the company’s CSE share price trades at $0.50 for 10 consecutive trading days; hold periods expire four months and one day from issuance. The company paid $75,000 in cash commissions. Proceeds are earmarked for operating expenses, legal and audit fees, working capital, market exploration for SureNano surfactant, and evaluating potential business combinations or acquisitions.

Positive

• Capital raised of $1,250,000
• Issued 10,000,000 units for immediate funding
• Warrants provide potential future equity financing at $0.35

Negative

• Immediate issuance of 10,000,000 common shares (dilution)
• Potential additional dilution from 10,000,000 warrants and 600,000 finder’s warrants
• Cash commissions of $75,000 paid to finders

Key Figures

Private placement size $1,250,000 Non-brokered private placement proceeds

Units issued 10,000,000 units Private placement issuance

Unit price $0.125 per Unit Private placement pricing

Warrant exercise price $0.35 per Common Share Investor Warrants and Finder’s Warrants

Warrant term 24 months Duration of Warrants and Finder’s Warrants

Hold period 4 months and 1 day Statutory hold on issued securities

Cash commissions $75,000 Finder compensation for private placement

Finder’s warrants issued 600,000 warrants Compensation to brokerage firms and agents

Market Reality Check

$0.2412 Last Close

Volume Volume 1,000 is in line with the 1,000 share 20-day average. normal

Technical Trading above 200-day MA, with price at $0.0971 versus MA(200) at $0.06.

Peers on Argus

Peers in Specialty Chemicals were mostly flat, with one peer up 5.68%, compared to SURNF’s pre-news move of 598.56%, indicating stock-specific dynamics.

Market Pulse Summary

This announcement detailed the closing of a non-brokered private placement raising $1,250,000 through 10,000,000 units at $0.125, each including a share and a warrant exercisable at $0.35 for 24 months. Proceeds are earmarked for operating expenses and potential business combinations. Investors may focus on how efficiently this capital is deployed, the impact of new warrants on future share supply, and any follow-on transactions the board approves.

Key Terms

private placement financial

"it has closed its non-brokered private placement to raise $1,250,000"

A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.

warrant financial

"one Common Share purchase warrant (each a "Warrant"), with each Warrant entitling"

A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.

finder's warrants financial

"issued an aggregate of 600,000 finder's warrants (the "Finder's Warrants")"

Finder's warrants are options given to an intermediary as payment for introducing a buyer, investor, or deal — they work like a coupon that lets the holder buy company shares at a fixed price for a set period. They matter to investors because exercising those warrants increases the number of shares outstanding, which can dilute existing owners, while also bringing potential cash into the company and signaling the cost of making the deal happen.

acceleration provision financial

"subject to the Acceleration Provision"

An acceleration provision is a clause in a contract that makes payments, ownership rights, or other obligations become due earlier than originally scheduled when a specific event happens, like a sale, takeover, bankruptcy, or other trigger. For investors, it matters because it can speed up when cash must be paid or when shares/options become owned by someone, changing the timing of returns, potential dilution, and credit risk much like a traffic signal suddenly turning green and forcing movement sooner than expected.

hold period regulatory

"are subject to a hold period under applicable Canadian securities laws"

A hold period is a specific span of time during which an investor is required or expected to keep a security or asset and cannot freely sell it or realize its value. It matters because it limits liquidity and can affect tax treatment, risk exposure and timing of gains or losses—like a cooling-off or fixed-term commitment that prevents you from quickly cashing out even if market conditions change.

AI-generated analysis. Not financial advice.

Vancouver, British Columbia--(Newsfile Corp. - December 10, 2025) - SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") is pleased to announce, as a follow-up to its news release dated November 5, 2025, that it has closed its non-brokered private placement to raise $1,250,000 through the issuance of 10,000,000 units (each a "Unit") at a price of $0.125 per Unit.

Each Unit is comprised of one common share (a "Common Share") and one Common Share purchase warrant (each a "Warrant"), with each Warrant entitling the holder thereof to acquire one Common Share in the capital of the Company at a price of $0.35 per Common Share for a period of 24 months from the date of issuance. The Warrants will be subject to an acceleration provision, such that if at any time after the date that is four months and one day after the closing, the Company's Shares trade on the Canadian Securities Exchange (the "CSE") at a closing price of $0.50 or greater per Share for a period of ten (10) consecutive trading days, the Company may accelerate the expiry of the Warrants by giving notice to the holders thereof and, in such case, the Warrant will expire on the thirtieth (30th) day after the date of such notice (the "Acceleration Provision").

In consideration for their services in introducing subscribers to the Company under the Private Placement, finders may receive commission of 6% cash and 6% common share purchase warrants, exercisable to purchase one common share at a price of $0.35 for a period of 24 months.

In connection with the private placement, the Company paid cash commissions of $75,000 and issued an aggregate of 600,000 finder's warrants (the "Finder's Warrants") to certain brokerage firms and agents for introducing subscribers to the Company. Each Finder's Warrant entitles the holder to receive one Common Share in the capital of the Company at a price of $0.35 per Common Share for a period of 24 months from the date of issuance, subject to the Acceleration Provision.

The Common Shares, Warrants and Finder's Warrants, together with all securities which may be issued on exercise, are subject to a hold period under applicable Canadian securities laws expiring four months and one day from the date of issuance.

The Company intends to use proceeds of the Private Placement for operating expenses, including legal and audit fees, general working capital, expenses related to exploring new markets for its SureNano^TM surfactant, and continuing to evaluate potential business combinations with complementary companies. In the event that the Board approves one or more potential transactions, then the proceeds will also be used toward entering into one or more agreements relating to business combinations or acquisitions and completing the business combination or acquisition transactions. The forward-‎looking information contained in this news release represents the expectations of the Company as of the date ‎of this news release and, accordingly, is subject to change after such date. The Company expressly ‎disclaims any intention or obligation to update or revise any forward-looking information, whether as a result ‎of new information, future events or otherwise, except as expressly required by applicable securities law.

About SureNano Science Ltd.:
The business of SureNano Science Ltd. is the sale and distribution of the SureNano™ surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nanoemulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity, and taste. The Company has an exclusive license to distribute the SureNano^TM surfactant within Canada; Oklahoma, USA; and Colorado, USA.

ON BEHALF OF SURENANO SCIENCE LTD.

"Charles MaLette"
CEO, President, Director & Secretary
T: 604-428-5171
E: info@surenano.com

Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of SureNano. Forward-looking information is based on certain key expectations and assumptions made by the management of SureNano. In some cases, you can identify forward-looking statements by the use of words such as "will," "may," "would," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "could" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements in this press release include that a) the Warrants will be accelerated as described above and b) the Company will use the proceeds as described. Although SureNano believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because SureNano can give no assurance that they will prove to be correct.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277545

FAQ

What did SureNano (SURNF) announce on December 10, 2025?

SureNano closed a non-brokered private placement raising $1,250,000 by issuing 10,000,000 units at $0.125 per Unit.

What are the warrant terms in the SureNano (SURNF) private placement?

Each Unit includes one warrant exercisable at $0.35 for 24 months, subject to an acceleration provision if CSE price hits $0.50 for 10 consecutive days.

How will SureNano (SURNF) use the $1,250,000 raised?

Proceeds will fund operating expenses, legal and audit fees, general working capital, market exploration for SureNano surfactant, and evaluating business combinations.

What finder fees did SureNano (SURNF) pay in the private placement?

The company paid $75,000 in cash commissions and issued 600,000 finder’s warrants exercisable at $0.35 for 24 months.

When do the hold periods and warrant expiry windows end for SureNano (SURNF)?

Securities are subject to a hold period expiring four months and one day from issuance; warrants expire after 24 months unless accelerated.